NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein PanCancer Immune Profiling Panel

More:
nCounterRNA:Protein pancancer immune profiling panel launched by NanoString